The Scholarly Activity Support Division focuses on the development of faculty directed, investigator initiated clinical research by: Assisting investigators with research design, development, and regulatory support including: Protocol development Grant development, preparation, and submission Completion of Investigational New Drugs (IND)/Investigational Device Exemption Applications (IDE)Safety monitoring Clinical study registration Helping provide a career development pathway for clinical research faculty Specific services include clinical research education, training and career development.

FREE CME Participants will be able to: •Make high quality, effective recommendations for HPV vaccination as cancer prevention for every 11 or 12-year-old patient. •Assess HPV vaccine coverage for each provider in your practice and develop an office-wide strategy to improve it. •Implement systems strategies to improve HPV vaccine coverage. •Engage the entire practice, not just the healthcare providers, in committing to improve HPV vaccine coverage.

The Center for Clinical Research (CCR) at SIU School of Medicine is dedicated to bringing the latest advanced treatment options and technology to our patients. For more information about potential participation in clinical trials at SIU, please contact the Center for Clinical Research at 217-545-9700, or complete our online recruitment survey located here: Patient Recruitment Survey The information you provide in the recruitment survey may be used to contact you if a potential participation opportunity is identified. Your information will be retained in a confidential, secure database. At any

Resident Presentations (Within Five Years): Kendroud, Sarah; Farooqi, Mehwish; El Kouzi, Ahmad; Arnold, Jennifer. “A 31-Year Old Male with Autosomal Dominant Adult-Onset Leukodystrophy". American Neurological Association (ANA) October, 2022. Kendroud, Sarah; Abbas, Ahmed; Showraki, Alireza. "A 55-Year Old Female with Periodic Hypothermia Caused by a Hypothalamic Cavernoma". American Neurological Association (ANA) October, 2022. Kendroud, Sarah; Thaliath, Andrew; Kulacz, Jeremy. “A Case of Spontaneous Right Internal Carotid Artery Dissection Presenting with Horner Syndrome after Diving”. (ISNS

Where are our graduates now? Year Graduated: 2022 Ahmed Abbas, MD – Fellow at University of Pittsburgh Medical Center in Multiple Sclerosis (MS), July, 2022. Mehwish Farooqi, MD – Fellow at Southern Illinois University School of Medicine, Springfield, IL for Movement Disorder, July, 2022. Cory Sykora, MD – General Neurology at Sanford Neurology Clinic, Sioux Falls, SD, July, 2022. Ria Asuncion, MD - Graduated Movement Disorder Fellowship, June, 2022. In Neurology Residency Program at Southern Illinois University School of Medicine, June, 2022-2026. 2021 Joshua Battley, MD – Fellow at

Neurology Residents' Clinic The Neurology Clinic is located on the 3rd Floor of the SIU Clinic’s Building, (Moy Building) 751 N. Rutledge, Room 3100. Continuity Clinics are held one half-day per week. Residents usually see 2 new patients and 4 or 5 follow up patients in each clinic. The combination changes as needed to accommodate the residents’ patient populations. Clinics should not be cancelled . Residents are expected to cover each other’s clinic as needed for vacations, interviews, etc. Exceptions: If a resident is attending The American Academy of Neurology Annual Meeting, sitting for

How to Apply for Residency Positions Application Criteria: All candidates must apply through ERAS . No pre-match positions will be offered Preliminary year of training is provided. Applicants can be no more than 5 years post MD graduation. USMLE 1 and COMPLEX-USA Level 1 with Pass on the first try. USMLE 2 score must be at least 215 on the exam on the first attempt or COMLEX-USA 2 CE ≥ 500. We sponsor J1 Visa, no H1B. We offer 4 spots each year. We begin accepting applications in September each year. Applications are reviewed on a first-come, first serve basis. Once the interview schedule is

Discovery research and clinical trials at the Simmons Cancer Institute at SIU provides the novel findings in cancer biology which will translate to better detection, treatment, and prevention options in the future. Research efforts are revealing fresh aspects in cellular and molecular mechanisms promoting tumor growth and metastases, new biomarkers for earlier detection and monitoring of therapeutic interventions, innovative agents and approaches for the treatment and prevention of cancer growth and proliferation. Simmons Cancer Institute research members performing these discovery-based